These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30558078)

  • 1. The efficacy of first-line regimens for Helicobacter pylori eradication in different continents: A systematic review and network meta-analysis protocol.
    Zamani M; Zamani V; Derakhshan MH; Shokri-Shirvani J
    Medicine (Baltimore); 2018 Dec; 97(50):e13682. PubMed ID: 30558078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and safety of vonoprazan-based regimen for Helicobacter pylori eradication: A meta-analysis of randomized clinical trials.
    Yang C; Li S; Huang T; Lin H; Jiang Z; He Y; Yuan J; An H
    J Clin Pharm Ther; 2022 Jul; 47(7):897-904. PubMed ID: 35247003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of second-line regimens for
    Chang YL; Tung YC; Tu YK; Yeh HZ; Yang JC; Hsu PI; Kim SE; Wu MF; Liou WS; Shiu SI
    BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32883715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential versus standard triple first-line therapy for Helicobacter pylori eradication.
    Nyssen OP; McNicholl AG; Megraud F; Savarino V; Oderda G; Fallone CA; Fischbach L; Bazzoli F; Gisbert JP
    Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD009034. PubMed ID: 27351542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimum duration of regimens for Helicobacter pylori eradication.
    Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication.
    Fontes LES; Martimbianco ALC; Zanin C; Riera R
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012357. PubMed ID: 30746681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-line
    Yeo YH; Shiu SI; Ho HJ; Zou B; Lin JT; Wu MS; Liou JM; Wu CY;
    Gut; 2018 Jan; 67(1):20-27. PubMed ID: 27670375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: A Network Meta-analysis.
    Rokkas T; Gisbert JP; Malfertheiner P; Niv Y; Gasbarrini A; Leja M; Megraud F; O'Morain C; Graham DY
    Gastroenterology; 2021 Aug; 161(2):495-507.e4. PubMed ID: 33839101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Helicobacter pylori eradication therapy for treatment of functional dyspepsia: A protocol for systematic review and meta-analysis.
    Wang J; Gu S; Qin B
    Medicine (Baltimore); 2021 May; 100(20):e26045. PubMed ID: 34011117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and network meta-analysis: Comparative effectiveness of therapies for second-line Helicobacter pylori eradication.
    Yeo YH; Hsu CC; Lee CC; Ho HJ; Lin JT; Wu MS; Liou JM; Wu CY;
    J Gastroenterol Hepatol; 2019 Jan; 34(1):59-67. PubMed ID: 30169908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical therapeutic effects of eradication of Helicobacter pylori in treating patients with type 2 diabetes mellitus: A protocol for systematic review and meta-analysis.
    Shi ZG; Chen LH
    Medicine (Baltimore); 2021 Jul; 100(27):e26418. PubMed ID: 34232174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological regimens for eradication of Helicobacter pylori: an overview of systematic reviews and network meta-analysis.
    Xin Y; Manson J; Govan L; Harbour R; Bennison J; Watson E; Wu O
    BMC Gastroenterol; 2016 Jul; 16(1):80. PubMed ID: 27460211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis.
    Kuo YT; Liou JM; El-Omar EM; Wu JY; Leow AHR; Goh KL; Das R; Lu H; Lin JT; Tu YK; Yamaoka Y; Wu MS;
    Lancet Gastroenterol Hepatol; 2017 Oct; 2(10):707-715. PubMed ID: 28781119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Traditional Chinese medicine for Helicobacter pylori infection: A protocol for a systematic review and meta-analysis.
    Zhao M; Jiang Y; Chen Z; Fan Z; Jiang Y
    Medicine (Baltimore); 2021 Jan; 100(3):e24282. PubMed ID: 33546052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials.
    Lin LC; Hsu TH; Huang KW; Tam KW
    World J Gastroenterol; 2016 Jun; 22(23):5445-53. PubMed ID: 27340362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility-guided sequential strategy versus empirical therapy for Helicobacter pylori infection: study protocol for a randomised controlled trial.
    Lu K; Lang C; Zou X; Zang L; Sang W; Feng Q; Mu Y; Liu L; Xu C; Zhao J
    Trials; 2023 Jun; 24(1):413. PubMed ID: 37337241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone Sequential Therapy for Helicobacter pylori: A Meta-analysis.
    Kale-Pradhan PB; Mihaescu A; Wilhelm SM
    Pharmacotherapy; 2015 Aug; 35(8):719-30. PubMed ID: 26173786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard Triple Therapy as a Remedy for Treatment of
    Kiani F; Khademolhosseini S; Fathi M; Tavasol A; Mohammadi J; Dousti M; Hoseini JE
    Curr Rev Clin Exp Pharmacol; 2023; 18(2):167-181. PubMed ID: 35301958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.